108 filings
6-K
SLN
Silence Therapeutics Plc
15 Apr 24
Current report (foreign)
7:00am
20-F
2023 FY
SLN
Silence Therapeutics Plc
Annual report (foreign)
13 Mar 24
8:52am
6-K
SLN
Silence Therapeutics Plc
13 Mar 24
Current report (foreign)
7:10am
6-K
SLN
Silence Therapeutics Plc
23 Feb 24
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca
8:12am
6-K
SLN
Silence Therapeutics Plc
6 Feb 24
Securities Purchase Agreement
12:00am
6-K
rn1f6k 9jm
1 Dec 23
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
7:00am
6-K
p1jgdz4
14 Nov 23
Current report (foreign)
12:00am
6-K
fdhy2nah
1 Nov 23
Current report (foreign)
7:00am
6-K/A
ftgha9jqzu5rrj
29 Aug 23
Current report (foreign) (amended)
4:01pm
6-K
n589y9xz
16 Aug 23
Current report (foreign)
7:00am
S-8
rq0sdul
1 Aug 23
Registration of securities for employees
4:31pm
6-K
sv7yt
11 Jul 23
Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration
7:00am
6-K
d73qh3jczdktaa
3 Jul 23
Current report (foreign)
7:30am
6-K
d63vg7 i5hbl1
16 May 23
Current report (foreign)
4:01pm
6-K
h680yxnmuhzby1d7mz
4 May 23
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
7:41am
6-K
acri1u4glf19z69w
1 May 23
Current report (foreign)
7:31am
6-K
7a5up46ebxa3148cr
27 Apr 23
Current report (foreign)
4:31pm
6-K
zon ukoyd297
28 Mar 23
Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
8:00am
6-K
y0mju
12 Jan 23
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
4:30pm